HeartBeam, Inc. (BEAT) News
Follow HeartBeam, Inc. (BEAT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Weekly Recap: ALIGN-ACS fast enrollment and 12—lead patch FDA progress
HeartBeam, Inc. (NASDAQ:BEAT) quickly completed ALIGN-ACS enrollment and will present results at TCT 2026 while HEADSTART-ACS advances and a pre-submission to the FDA targets a pivotal MI study; its 12—lead patch moves t
REGULATION | Sep 28, 2026, 11:03 AM UTC
L
BEAT - Patent talk on name
BEAT - Patent talk on name
NEWS | Sep 15, 2026, 07:57 PM UTC
L
HeartBeam Says US Patent Expands Capabilities of Portable ECG Device
() -- HeartBeam (BEAT) said Tuesday it received a new US patent covering acoustic sensing and thoracic impedance measurement for its portable ECG device, expanding the platform's potential use in monitoring structural he
MNA | Jul 14, 2026, 11:34 AM UTC
L
HeartBeam shares are trading higher after the company announced completion of patient enrollment in its ALIGN-ACS pilot study evaluating the
HeartBeam shares are trading higher after the company announced completion of patient enrollment in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection.
EQUITY | Jun 30, 2026, 03:31 PM UTC
M
BEAT Shifts Strategy
BEAT HeartBeam announces a strategic shift to accelerate global adoption of its ambulatory ECG signal platform and undergoes a leadership transition
EQUITY | Jun 24, 2026, 08:05 PM UTC